Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q3 2022 vs. Q2 2022
How the institutions holding Sunshine Biopharma Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 18 | 12 | −6 |
| Shares | 737.5K | 429.4K | −308.0K (−41.8%) |
| Value | $802.1K | $341.1K | −$461.0K (−57.5%) |
New holders (2)
Institutions that held Sunshine Biopharma Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 37,386 | $29.0K | 0.00% |
| Susquehanna International Group, LLP | 13,849 | $11.0K | 0.00% |
Sold out (8)
Institutions that held Sunshine Biopharma Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Virtu Financial LLC | 47,861 | $52.0K |
| Dakota Wealth Management | 20,000 | $22.0K |
| Tower Research Capital LLC (TRC) | 8,128 | $9.00K |
| Morgan Stanley | 6,867 | $7.00K |
| Captrust Financial Advisors | 1,464 | $2.00K |
| Citigroup Inc | 130 | $0 |
| Signaturefd, LLC | 300 | $0 |
| Larson Financial Group LLC | 127 | $0 |